Author | Number | % Interface hepatitis (n) | % Plasma cell prominence | % Rosettes | % Emperipolesis | % Portal tract/bile duct lesions | Other features | ||||||
AIH | C | AIH | C | AIH | C | AIH | C | AIH | C | AIH | C | AIH | |
Suzuki et al 16 | 28 | 19* | 100 | 100 | 86 | 32 | 75 | 41 | 75 | 37 | 57 | 53 | |
de Boer et al 17 | 63 | 62† | 87 | 63 | 48 | 27 | 49 | 23 | 78 | 50 | 28 | 18 | Steatosis 3 Granuloma 11 |
Balitzer et al 18 | 88 | 20‡ 13§ | 80 | 15 77 | 49 | 20 8 | 33 | 0 38 | 65 | 50 77 | 46 | 100 62 | Copper, CK-199 stains |
Gurung et al 19 | 43 | 42† | 65 | 40 | 60¶ | 26¶ | 37 | 17 | 51 | 24 | 60 | 25 | Endotheliitis Kupffer cell hyaline |
Median (range) | 83 (65–100) | 63 (15–100) | 55 (48–86) | 26 (8–32) | 43 (33–75) | 23 (0–41) | 70 (51–78) | 50 (24–77) | 51 (28–60) | 53 (25–100) |
*DILI (hepatocellular).
†Chronic viral hepatitis.
‡PBC.
§Non-autoimune.
¶Defined as plasma cell clusters.
AIH, autoimmune hepatitis; DILI, drug-induced liver injury; PBC, primary biliary cholangitis.